Allergan
Allergan[edit]
Allergan plc is a global pharmaceutical company specializing in aesthetics, eye care, neurosciences, and gastrointestinal treatments.
Overview[edit]
Founded as a small eye care company, Allergan has since grown into a multifaceted pharmaceutical giant, known especially for its product Botox.
History[edit]
- 1948: Allergan was founded by Gavin S. Herbert to produce nose drops and an anti-allergy medication in Los Angeles.
- 1950s: The company expanded into eye care products, launching its first blockbuster drug, an eye drop.
- 1980s-1990s: Allergan expanded globally, establishing its presence in over 100 countries.
- 2015: Allergan was acquired by Actavis plc, which then adopted the name Allergan.
- 2020: AbbVie acquired Allergan in a deal worth approximately $63 billion.
Notable Products[edit]
- Botox (onabotulinumtoxinA): A neurotoxin used for various cosmetic and therapeutic treatments.
- Restasis: A medication used to increase tear production in people with dry eyes.
- Juvederm: A range of injectable dermal fillers.
- CoolSculpting: A non-surgical body contouring treatment.
Research and Development[edit]
Allergan has been at the forefront of R&D in its specialized fields, with a focus on patient-centric innovation. Its R&D centers globally collaborate on drug discovery and development.
Corporate Social Responsibility[edit]
Allergan has committed itself to sustainability, patient welfare, and community service. Their initiatives include patient assistance programs, donations, and environmental sustainability practices.
Controversies[edit]
Allergan has faced its share of controversies, especially related to drug pricing, patents, and FDA regulations.
Facilities[edit]
With its global presence, Allergan has R&D, manufacturing, and commercial operations located in various regions around the world.
See Also[edit]
References[edit]
- [1] "Allergan: Our History". Allergan Official Website.
- [2] "The Evolution of Allergan". Pharmaceutical Executive Magazine.
- [3] "AbbVie Completes Acquisition of Allergan". Reuters.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
